The groundbreaking treatment of the medication represents a major breakthrough in the management of type 2 diabetes. Unlike existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment